eHealth Initiative

ehidc.org

eHealth Initiative and Foundation (eHI) is a Washington DC-based, independent, non-profit organization whose mission is to drive improvements in the quality, safety, and efficiency of healthcare through information technology. eHI is a multi-stakeholder collaborative, convening executives from every group in healthcare, to discuss, identify, and share best practices that transform the delivery of healthcare. Working with its membership, eHI advocates for the use of health IT that is practical, sustainable, and addresses stakeholder needs, particularly those of patients.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

ETHYPHARM TO ACQUIRE ALTAN PHARMA, ALLOWING IT TO ENTER THE SPANISH MARKET AND EXPAND ITS CRITICAL CARE PORTFOLIO AND R&D PIPELINE.

Ethypharm | June 19, 2021

news image

Ethypharm reports today that it has entered into a definitive agreement to acquire Altan Pharma, a specialty pharmaceutical company that develops, manufactures and markets injectable medicines for hospital use. On account of the strong presence of Altan Pharma in Spain, Ethypharm will reach full commercial coverage of the main 5 European markets after shutting, which is expected in the second half of 2021. Ethypharm will likewise profit with an enlarged portfolio of great hospital...

Read More

TETRA BIO-PHARMA ENGAGES ALPHA BRONZE LLC AS INVESTOR RELATIONS AND PUBLIC RELATIONS FIRM

Send Press Releases with GlobeNewswire | March 06, 2020

news image

Tetra Bio-Pharma Inc a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has engaged Alpha Bronze LLC., by its principal, Mr. Pascal Nigen, an investor relations, management consulting and financial communications firm to implement and execute a comprehensive investor relations and communications program. “I am very pleased and excited to have engaged Alpha Bronze as our new IR firm. They have demonstrated in a recent mandate provided to them that...

Read More

Business Insights

KYOWA KIRIN EXPANDS LICENSE AGREEMENT WITH SYNAFFIX AND TAKES EXCLUSIVE TARGET RIGHTS BASED ON LATEST POSITIVE ADC DATA

Synaffix | July 01, 2022

news image

Synaffix B.V. a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates with best-in-class therapeutic index, today announces that Kyowa Kirin Co., Ltd.a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, has expanded the license agreement with Synaffix by adding a third ADC target to its research evaluation and development effor...

Read More

CPD and Learning

MIRAVO AND SEARCHLIGHT CLOSE PREVIOUSLY ANNOUNCED ARRANGEMENT PLAN

Miravo Healthcare | March 16, 2023

news image

Nuvo Pharmaceuticals Inc., which operates as Miravo Healthcare (Miravo), and Searchlight Pharma Inc., a Canadian specialty firm, have recently announced the closing of the previously announced plan of arrangement of Miravo with Searchlight. As per the arrangement terms, Searchlight acquired all the outstanding common shares of Miravo in exchange for $1.35 per share in cash, and the Miravo common shares will be removed from the Toronto Stock Exchange. Miravo will also apply to cease being a...

Read More
news image

Research

ETHYPHARM TO ACQUIRE ALTAN PHARMA, ALLOWING IT TO ENTER THE SPANISH MARKET AND EXPAND ITS CRITICAL CARE PORTFOLIO AND R&D PIPELINE.

Ethypharm | June 19, 2021

Ethypharm reports today that it has entered into a definitive agreement to acquire Altan Pharma, a specialty pharmaceutical company that develops, manufactures and markets injectable medicines for hospital use. On account of the strong presence of Altan Pharma in Spain, Ethypharm will reach full commercial coverage of the main 5 European markets after shutting, which is expected in the second half of 2021. Ethypharm will likewise profit with an enlarged portfolio of great hospital...

Read More
news image

TETRA BIO-PHARMA ENGAGES ALPHA BRONZE LLC AS INVESTOR RELATIONS AND PUBLIC RELATIONS FIRM

Send Press Releases with GlobeNewswire | March 06, 2020

Tetra Bio-Pharma Inc a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has engaged Alpha Bronze LLC., by its principal, Mr. Pascal Nigen, an investor relations, management consulting and financial communications firm to implement and execute a comprehensive investor relations and communications program. “I am very pleased and excited to have engaged Alpha Bronze as our new IR firm. They have demonstrated in a recent mandate provided to them that...

Read More
news image

Business Insights

KYOWA KIRIN EXPANDS LICENSE AGREEMENT WITH SYNAFFIX AND TAKES EXCLUSIVE TARGET RIGHTS BASED ON LATEST POSITIVE ADC DATA

Synaffix | July 01, 2022

Synaffix B.V. a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates with best-in-class therapeutic index, today announces that Kyowa Kirin Co., Ltd.a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, has expanded the license agreement with Synaffix by adding a third ADC target to its research evaluation and development effor...

Read More
news image

CPD and Learning

MIRAVO AND SEARCHLIGHT CLOSE PREVIOUSLY ANNOUNCED ARRANGEMENT PLAN

Miravo Healthcare | March 16, 2023

Nuvo Pharmaceuticals Inc., which operates as Miravo Healthcare (Miravo), and Searchlight Pharma Inc., a Canadian specialty firm, have recently announced the closing of the previously announced plan of arrangement of Miravo with Searchlight. As per the arrangement terms, Searchlight acquired all the outstanding common shares of Miravo in exchange for $1.35 per share in cash, and the Miravo common shares will be removed from the Toronto Stock Exchange. Miravo will also apply to cease being a...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us